SHIRLe is named for Shirley.
The work the product has to do is the work the family has been doing on behalf of patients for three generations.
A.R. Henderson operates SHIRLe through Precision Health Ventures. He comes from three generations of working through a healthcare system that was not built for the people in his family.
His father, Arthur Henderson Sr., practiced medicine and psychiatry in Washington, DC for roughly forty years while living with polio-related disability from childhood. His sister chaired the Women Against MS luncheon for years before her own MS progressed; she is now mostly bedridden and losing her speech. His mother, Shirley Henderson, is the platform’s namesake.
This is not background. It is the reason the product is built the way it is — patient-controlled, durable through changing capacity, designed for caregivers, accessible as a first commitment rather than an afterthought.
SHIRLe is not a startup proving an unproven approach. The operating team has a decade of federal deployment experience in disability-adjacent and chronic-disease populations, executed through Precision Health Ventures’ sister clinical platform IntelaCare.
IntelaCare was selected by the Department of Veterans Affairs Innovation Initiative (VAi2) approximately a decade ago to deliver TBI, PTSD, diabetes, and chronic disease management content to veterans through cell phones and broadband home devices, demonstrating daily engagement as high as 70%. A multimillion-dollar VA contract supported TBI care at the Palo Alto Veterans Center. Multiple Army Medical Command innovation grants funded diabetes work at Walter Reed Medical Center.
This is the credibility floor beneath SHIRLe, not the SHIRLe pitch itself. It is the answer to “have you done this before?”
A.R. Henderson is Managing Partner of Precision Health Ventures. AAPD Technology Task Force (multi-year service). Former advisor to Paralyzed Veterans of America. Advisor to the FCC Connect2Health Task Force. Participant on the White House Precision Medicine Task Force. Member of the CMS Federal Advisory Committee on Consumer Engagement under the Obama administration. Stanford Program for Growing Companies alumnus. NVIDIA Inception/AI partner.
IntelaCare is the Medicare-enrolled clinical AI platform, positioned for the CMS ACCESS Model launching July 5, 2026. It is pursuing FDA Software as a Medical Device certification. Ben Scott, MD serves as Medical Director.
SHIRLe Health is the patient-controlled intelligence layer. It is in active development. Alpha surfaces — the HealthDigits AVS scanner and the screenshot ingestion prototype — are deployable today. Data-fabric components launch with IntelaCare’s CMS ACCESS rollout in July 2026, which constitutes SHIRLe’s first federal production deployment.
HealthDigits is the sister ingestion brand. It currently lives within the SHIRLe ecosystem and will continue to grow as a standalone surface for users who want a simpler tool.
Architected with care.